Skip to main content
An official website of the United States government
Español
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

gemcitabine hydrochloride

(jem-SY-tuh-been HY-droh-KLOR-ide)
A drug used alone or with other drugs to treat certain types of breast, non-small cell lung, ovarian, and pancreatic cancers that are advanced or have spread to other parts of the body. It is also being studied in the treatment of other types of cancer. Gemcitabine hydrochloride stops cells from making DNA and may kill cancer cells. It is a type of antimetabolite. Gemcitabine is the active ingredient of gemcitabine hydrochloride. Also called Gemzar and Infugem.
Search NCI's Dictionary of Cancer Terms